Skip to content
  • Home
  • Bureaucracy Updates
    • PSU
  • Current News
  • State
  • Corporate
  • Central Government Schemes
  • Latest News
    • Health & Fitness
  • Events
  • Health & Fitness
  • PSU
  • International

INDIA BUREAUCRACY – News from Indian Bureaucracy Diaspora

India Bureaucracy, Bureaucracy News, IAS,IPS, Transfers, Postings, News from government bodies & global news

  • Home
  • Bureaucracy Updates
    • PSU
  • Current News
  • State
  • Corporate
  • Central Government Schemes
  • Latest News
    • Health & Fitness
  • Events
  • Health & Fitness
  • PSU
  • International

Flash News

screenshot 2025 12 21 10 54 23 920 com.android.chrome

Rakesh Gupta IRS-IT, appointed as DGIT Vigilance/ Chief Vigilance Officer in Central Board of Direct Taxes (CBDT)

screenshot 2025 12 21 14 46 09 448 com.android.chrome

Four members of State Police Service in Madhya Pradesh promoted as IPS.

rvnllogo

Saleem Ahmad assume charge as the new Chairman and Managing Director (CMD) of Rail Vikas Nigam Limited.

screenshot 2025 10 28 23 11 13 295 com.android.chrome

Six IAS officers of 2002 batch in Tamil Nadu belonging to Tamil Nadu cadre have been promoted to the Principal Secretary Grade.

Friday, March 06, 2026

Tag: gsk

GSK and MS Dhoni team up for 6 in 1 vaccination awareness campaign
Corporate Current News Health & Fitness

GSK and MS Dhoni team up for 6 in 1 vaccination awareness campaign

India bureaucracy March 9, 2022

Posted on : 9th March ,2022 GSK and MS Dhoni team up for 6 in 1 vaccination awareness campaign GSK launches a new public interest campaign featuring MS Dhoni, to … Read More

6 in 1 vaccinationgskGsk dhonim s dhoni
GLAXO SMITHKLINE SELLS RIGHTS TO NOVARTIS AG OF DRUG USED IN TREATING AUTOIMMUNE DISEASES
Corporate

GLAXO SMITHKLINE SELLS RIGHTS TO NOVARTIS AG OF DRUG USED IN TREATING AUTOIMMUNE DISEASES

India bureaucracy August 22, 2015

LONDON—  GlaxoSmithKline PLC is selling its remaining rights to a drug for use in treating autoimmune diseases, including multiple sclerosis, to Novartis  AG for up to $1 billion, plus royalties. Glaxo … Read More

as the drug is knowngalxo smithklinegskincluding multiple sclerosisLONDON— GlaxoSmithKlinePLC is selling its remaining rights to a drug for use in treating autoimmune diseasesplus royalties. Glaxo said on Friday that Novartis will own rights to ofatumumabto Novartis AG for up to $1 billion

March 2026
MTWTFSS
 1
2345678
9101112131415
16171819202122
23242526272829
3031 
« Dec    

Informative Links

IAS officers Posting

https://dopt.gov.in/posting-of-ias-officers-list

Proudly powered by WordPress | Theme: TimesNews | By Theme Freesia.